5-[(3,4-dihydroxyphenyl)methyl]oxolan-2-one

Description

5-[(3,4-dihydroxyphenyl)methyl]oxolan-2-one Basic Attributes

Characteristics

Drug Information

Computed Properties

Latest News on 5-[(3,4-dihydroxyphenyl)methyl]oxolan-2-one

• Forecast and analysis of market size and entry barriers of China's pharmaceutical intermediates industry
• Pharmaceutical intermediates: the future development of adenine

Learn More Other Chemicals

• 2-[[2-[[1-(2-aminoethyl)piperidin-4-yl]amino]-4-methylbenzimidazol-1-yl]methyl]-6-methylpyridin-3-ol

  317846-22-3

• N-ethyl-2-methoxy-N-(2-methoxyethyl)ethanamine

  109907-05-3

• 4-[[(2R)-2-Hydroxy-3-methyl-3-buten-1-yl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one

  33783-80-1

• dodeca-5,7-dienal Formula

  75539-65-0

• (9-hydroxy-8,8-dimethyl-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl) 2-methylbut-2-enoate Formula

  150135-35-6

• 4,5-Dihydro-2-methylthiophene Formula

  4610-02-0

• 2-fluoro-1H-imidazole Structure

  57212-34-7

• 1,3-thiazol-5-ylmethyl N-[(2S,4S,5S)-4-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate Structure

  202816-62-4

• What is (3S)-morpholine-3-carboxylic acid

  106825-79-0

• What is [4-(hydroxymethyl)-2-(4-methoxyphenyl)-5H-1,3-oxazol-4-yl]methanol

  91642-17-0